NSE: NIFTYMIDCAP50

17093.65 86.80 (0.51%)

Near 52W High of ₹17498.55

NSE 18 Dec, 2025 3:20 PM (IST)

Nifty Midcap 50 PB	4.5
Nifty Midcap 50 PE	33.2
Nifty Midcap 50 DIV	0.8
Nifty Midcap 50 EPS	512.9

Nifty Midcap 50 News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Mankind Pharma Ltd. authored by BP Wealth and published by - Trendlyne research reports.
Item: Mankind Pharma Ltd.
Rating: 5
Author: BP Wealth

Keep track of all breaking news and updates on Nifty Midcap 50 from all sources in a single place.

Load latest

Is Nifty Midcap 50 worth buying?

84 Votes:

Buy 63.1%

Sell 23.81%

Hold 13.1%